Clinical trial
Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing…
NCT00003229 · Duke University, Other · Completed
Key facts
| NCT number | NCT00003229 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal |
| Official title | A Phase I-II Trial of Antigen-Pulsed Autologous Dendritic Cells for Induction of Anti-Tumor Immunity in Patients Completing Lymphadenectomy for Metastatic Melanoma |
| Lead sponsor | Duke University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | aldesleukin, gp100 antigen, tyrosinase peptide |
| Start date | Jul 1, 1997 |
| Primary completion | Apr 1, 2000 |
| Completion | Feb 1, 2005 |
| First posted | Aug 25, 2004 |
| Last update posted | Mar 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: